| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 05/31/2007 | WO2007061074A1 Novel bisboron compound |
| 05/31/2007 | WO2007060802A1 Solid pharmaceutical preparation and pharmaceutical preparation composition |
| 05/31/2007 | WO2007060132A1 N-hydroxyamide derivatives and use thereof |
| 05/31/2007 | WO2007060106A1 Aerosol formulation for inhalation containing an anticholinergic agent |
| 05/31/2007 | WO2007060105A1 Aerosol formulation for inhalation containing an anticholinergic agent |
| 05/31/2007 | WO2007060028A1 Napthyridine compounds as rock inhibitors |
| 05/31/2007 | WO2007059905A2 Thienopyrimidines treating inflammatory diseases |
| 05/31/2007 | WO2007059649A1 Chinese pharmaceutical compositions for treating upper respiratory tract infection and processes for preparation thereof |
| 05/31/2007 | WO2007059620A1 Method for administering formoterol using a nebulizer |
| 05/31/2007 | WO2007028524A3 Use of a derivative of imidazole for the treatment of leukotriene related disorders |
| 05/31/2007 | WO2007017687A3 Ep2 receptor agonists |
| 05/31/2007 | WO2007010499A3 Derivatives of monosaccharides for the treatment of copd and allergic rhinitis |
| 05/31/2007 | WO2007003957A3 Steroidal glycoside compounds as core 2 glcnac- t inhibitors |
| 05/31/2007 | WO2006110496A3 Activation of sodium potassium atpase |
| 05/31/2007 | WO2006074370A3 Agonists and antagonists of tnfrii/cd120b for treatment of immune-related diseases |
| 05/31/2007 | US20070124837 Desaturase genes, enzymes encoded thereby, and uses thereof |
| 05/31/2007 | US20070123566 Isoflavone derivatives of tectoridin, the preparation thereof and the anti-virus medicines containing the same as an effective constituents |
| 05/31/2007 | US20070123543 Novel compounds |
| 05/31/2007 | US20070123532 Piperazine derivatives |
| 05/31/2007 | US20070123530 e.g. (2-chloropyrimidin-4-yl)-(4-ethyl-3H-thiazol-2ylidene)-acetonitrile,[4-(4-chlorophenyl)-1,3-thiazol-2(3H)-ylidene](2-chloropyrimidin-4-yl)acetonitrile; Jun N-terminal kinase and Glycogen Synthase Kinase 3 inhibitor; antidiabetic, antiinflammatory, anticarcinogenic agent; neurodegenerative diseases |
| 05/31/2007 | US20070123521 Cinnamoyl derivatives and use thereof |
| 05/31/2007 | US20070123517 Pharmacological treatment for sleep apnea |
| 05/31/2007 | US20070123503 Cyclic salen-metal compounds: reactive oxygen species scavengers useful as antioxidants in the treatment and prevention of diseases |
| 05/31/2007 | US20070123455 Immunomodulatory agents for treatment of inflammatory diseases |
| 05/31/2007 | US20070122418 Compositions and methods for the pulmonary delivery of aerosolized medicaments |
| 05/31/2007 | US20070122354 possess superior aerosol properties, even in the absence of stabilizing carriers or excipients; inhalants; when administered to the deep lung, are useful for treating allergic diseases, such as asthma, atopy, and atopic dermatitis |
| 05/31/2007 | US20070122352 Inhalation Drug Combinations |
| 05/31/2007 | US20070122351 Inhalation Drug Combinations |
| 05/31/2007 | DE102005055961A1 Pharmaceutical composition containing specific concentration of quaternary ammonium anticholinergic agent, useful for treatment, by inhalation, of respiratory tract diseases |
| 05/31/2007 | CA2631017A1 Bisboron compounds for use as intracellular calcium concentration increase inhibitors |
| 05/31/2007 | CA2630551A1 N-hydroxyamide derivatives and use thereof |
| 05/31/2007 | CA2629074A1 Aerosol formulation for inhalation containing an anticholinergic agent |
| 05/31/2007 | CA2629073A1 Aerosol formulation for inhalation containing an anticholinergic agent |
| 05/31/2007 | CA2593718A1 Napthyridine compounds as rock inhibitors |
| 05/30/2007 | EP1790726A2 Modified and stabilized GDF propeptides and uses thereof |
| 05/30/2007 | EP1790725A2 Proteins named after FCTRX and nucleic acids encoding same |
| 05/30/2007 | EP1790687A2 Cereal beta glucan compositions, methods of preparation and uses thereof |
| 05/30/2007 | EP1790659A2 Polypeptides of pseudomonas aeruginosa |
| 05/30/2007 | EP1790652A1 Polycyclic guanine phosphodiesterase V inhibitors |
| 05/30/2007 | EP1790651A1 A1 adenosine receptor antagonists |
| 05/30/2007 | EP1790644A1 Substituted benzopyrans as selective estrogen receptor-beta agonists |
| 05/30/2007 | EP1790643A1 Quinuclidine compounds having quaternary ammonium group, it's preparation method and use as blocking agents of acetycholine |
| 05/30/2007 | EP1790639A1 Compound containing basic group and use thereof |
| 05/30/2007 | EP1790637A1 Nitrogenous heterocyclic derivative and medicine containing the same as an active ingredient |
| 05/30/2007 | EP1790352A1 Use of botulinum toxin type B for the manufacture of a medicament for reducing pain associated with a muscle disorder |
| 05/30/2007 | EP1789417A1 AMIDE DERIVATIVES OF 7-AMINO-3-PHENYL-DIHYDROPYRIMIDO [4,5-d]PYRIMIDINONES, THEIR MANUFACTURE AND USE AS PHARMACEUTICAL AGENTS |
| 05/30/2007 | EP1789405A1 Novel enantiomerically pure beta-agonists, method for the production and the use thereof in the form of a drug |
| 05/30/2007 | EP1789394A1 Hydroxy-substituted benzo-condensed heterocycles for use as beta agonists in the treatment of respiratory diseases |
| 05/30/2007 | EP1789138A2 Growth factor treatment for asthma |
| 05/30/2007 | EP1789060A1 Compositions comprising compounds capable of forming a reversible bond or association with gaseous nitric oxide |
| 05/30/2007 | EP1789056A1 Use of steroid-derived pharmaceutical compositions for treating disorders relating to pathological processes in lipid rafts |
| 05/30/2007 | EP1789049A2 Cyclic amide and ester pyrazinoylguanidine sodium channel blockers |
| 05/30/2007 | EP1789047A2 Treatment of diseases using nalmefene and its analgos |
| 05/30/2007 | EP1789036A2 5-ý3-(4-benzyloxyphenylthio)-fur-2-yl¨-imidazolidin-2, 4-dione and analogues as inhibitors of macrophage elastase |
| 05/30/2007 | EP1789034A1 Compounds with diphenoyl -structure for the treatment of immune diseases |
| 05/30/2007 | EP1789033A2 Glycine as a diet supplement for the treatment of health problems that result from underlying metabolic disorders |
| 05/30/2007 | EP1318814B1 Triazole compounds useful as protein kinase inhibitors |
| 05/30/2007 | EP1311663B1 Claudin polypeptides |
| 05/30/2007 | EP1257537B1 Therapeutic morpholino-substituted compounds |
| 05/30/2007 | EP0914605B1 Molecular model for vla-4 inhibitors |
| 05/30/2007 | CN1972936A Muscle relaxation accelerator and therapeutic agent for muscular tissue diseases such as muscle relaxation failure |
| 05/30/2007 | CN1972923A Piperidine derivatives as modulators of chemokine receptor ccr5 |
| 05/30/2007 | CN1972730A Glycopyrrolate for treating childhood asthma |
| 05/30/2007 | CN1972716A Combinations comprising antimuscarinic agents and beta-adrenergic agonists |
| 05/30/2007 | CN1970056A Taste improved 'Xin Xue' powder |
| 05/30/2007 | CN1970019A Chinese medicinal nasal wash and preparation method thereof |
| 05/30/2007 | CN1970012A Drop pills of negundo chastetree and preparation process thereof |
| 05/30/2007 | CN1969983A Quality control method of cough-stopping (Ke Ke) capsule |
| 05/30/2007 | CN1969982A Chinese hawthorn seed and application thereof in preparation of medicament for treating respiratory tract infection and air disinfectant |
| 05/30/2007 | CN1969953A Quality control method of honeysuckle, scutellarta root and extract thereof and formulation containing the extract |
| 05/30/2007 | CN1969944A Oral compound western and Chinese integrated medicine for treating asthma and preparation process thereof |
| 05/30/2007 | CN1969940A Antivirus pharmaceutical composition |
| 05/30/2007 | CN1969934A Ledum palustre Linn. oil drop pills for treating chronic bronchitis and preparation process thereof |
| 05/30/2007 | CN1969933A Drop pills of Dahurian rhododendron leaf oil for stopping cough and resolving phlegm and preparation process thereof |
| 05/30/2007 | CN1969932A Drop pills of rhogodendron lutescens franch for treating chronic bronchitis and preparation process thereof |
| 05/30/2007 | CN1969915A Drop pills of sweet wormwood oil for relieving cough and resolving phlegm and preparation process thereof |
| 05/30/2007 | CN1969914A Artemisia dubia Wall. ex Bess oil drop pill having sputum-dissolving cough-stopping asthma-relieving functions and preparation process thereof |
| 05/30/2007 | CN1969895A Enteric-coated formulation of creat and preparation process thereof |
| 05/30/2007 | CN1969873A Pharmaceutical composition combined by erdosteine with eight kinds of antibacterial medicament respectively |
| 05/30/2007 | CN1969850A Taste masked suspension prescription for treating infant cold and method for preparing same |
| 05/30/2007 | CN1969831A Capsule containing terramycin, oryzanol and vitamin for treating pharyngitis |
| 05/30/2007 | CN1969687A Crocodile meat preparation and production process thereof |
| 05/30/2007 | CN1318580C Mass preparation of SARS virus capable of meeting the production of inactivated vaccine and inactivation method |
| 05/30/2007 | CN1318573C Mycobacterium smegmatis preparation and use thereof |
| 05/30/2007 | CN1318564C Bitter bamboo wine and preparation method |
| 05/30/2007 | CN1318561C Caterpillar fungus yellow rice wine |
| 05/30/2007 | CN1318446C Transferrin receptor protein of Moraxella |
| 05/30/2007 | CN1318435C Cyclic salen-metal compounds as scavengers for oxygen radicals and useful as antioxidants in the treatment and prevention of diseases |
| 05/30/2007 | CN1318425C Cough and phlegm removing purple bergenia element analog and its pharmaceutical composition |
| 05/30/2007 | CN1318422C Substituted pyrazolopyrimidines and thiazolopyrimidines used as analgesics |
| 05/30/2007 | CN1318404C Aryl ureas as kinase inhibitors |
| 05/30/2007 | CN1318402C Pyrrolidine-2-carboxylic acid hydrozide derivatives for use as metalloprotease inhibitors |
| 05/30/2007 | CN1318091C Use of biologically active HIV-1 Tat, fragments or derivatives thereof for preventing or therapeutic vaccination and/or treating other diseases |
| 05/30/2007 | CN1318071C Chinese medicine preparation for treating bronchitis |
| 05/30/2007 | CN1318048C Prepared Chinese medicine for treating pneumonia |
| 05/30/2007 | CN1318026C Solid pharmaceutical formulations comprising modafinil |
| 05/30/2007 | CN1317979C Modified methionine rich food products and process for their manufacture |
| 05/29/2007 | US7223867 Preparation of benzosuberonylpiperidine compounds |
| 05/29/2007 | US7223858 Truncated aggrecanase molecules |
| 05/29/2007 | US7223839 Splice variants of the human H3 histamine receptor having deletions of portions of the N-terminal of the wild type H3 receptor; useful in methods for identifying agonists, inverse agonists or antagonists of histamine action at the H3 receptor; therapeutic and diagnostic agents; nervous system disorders |